Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Zhendong Anxin Pharmaceutical Co., Ltd. is a major manufacturing subsidiary of the Shanxi Zhendong Pharmaceutical Group, a leading player in the Chinese healthcare industry. Based in Jinzhong, Shanxi, the company operates advanced GMP-certified facilities dedicated to the production of a wide array of generic pharmaceuticals and nutritional supplements. Its product portfolio is particularly strong in gastroenterology, cardiovascular health, and metabolic disorders, featuring high-volume products such as omeprazole and calcium supplements. Zhendong Anxin serves as a critical production hub for the parent group, ensuring high standards of quality and supply for the domestic market. The company continues to expand its manufacturing capabilities and product pipeline to address prevalent health conditions in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhendong Anxin Pharmaceutical.